1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 20,200 | 20,800 | 08:18 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08:09 | Getinge invites fund managers, analysts, and media to Year-End Report 2025 conference call | 3 | Cision News | ||
| 19.12.25 | Getinge transforms sterile reprocessing with Automatiq - a full range of logistic automation modules | 7 | Cision News | ||
| 18.12.25 | Camilla Sylvest is proposed for Getinge AB's Board of Directors | 2 | Cision News | ||
| 25.11.25 | Getinge and SteriPro International Inc. announce strategic partnership for sterile processing optimization | 1 | Cision News | ||
| GETINGE AB ADR Aktie jetzt für 0€ handeln | |||||
| 20.11.25 | Getinge introduces new version of Solsus 66 to meet CSSD efficiency needs | 4 | Cision News | ||
| 13.11.25 | GETINGE: Utility-efficient washer-disinfector Aquadis 44 helps hospitals reduce costs and meet environmental targets | 1 | Cision News | ||
| 04.11.25 | Getinge boosts cleanroom efficiency with modern interface for cGMP washers and sterilizers | 2 | Cision News | ||
| 21.10.25 | Getinge Q3 Profit Surges; Confirms Annual Outlook | 455 | AFX News | STOCKHOLM (dpa-AFX) - Getinge AB (GETI-B.ST), a medtech company, on Tuesday reported a profit before tax of SEK 789 million for the third quarter, a sharp increase from SEK 32 million in the... ► Artikel lesen | |
| 21.10.25 | Getinge-Aktie steigt nach übertroffenen Quartalsergebnissen | 25 | Investing.com Deutsch | ||
| 21.10.25 | Getinge AB Non-GAAP EPS of SEK 2.42, revenue of SEK 8.23B; reaffirms FY outlook | 13 | Seeking Alpha | ||
| 21.10.25 | Getinge AB: Getinge Interim Report July-September 2025: High organic sales growth and stronger margins despite geopolitical headwinds | 180 | GlobeNewswire (Europe) | Press release
Gothenburg, Sweden on October 21, 2025
"We demonstrated strength in the third quarter with significant organic growth, improved profitability and cash flow despite impacts from tariffs... ► Artikel lesen | |
| 13.10.25 | Getinge's Advanta V12 receives CE Mark for major bridging indications | 2 | Cision News | ||
| 07.10.25 | Getinge invites fund managers, analysts, and media to Q3 Report 2025 conference call | 5 | Cision News | ||
| 02.10.25 | Philips, Getinge partner on anesthesia monitoring | 2 | MassDevice | ||
| 02.10.25 | Getinge and Philips introduce integrated anesthesia workstation | 2 | Cision News | ||
| 04.08.25 | Getinge earns reinstated CE mark for intra-aortic balloon pump | 2 | MassDevice | ||
| 04.08.25 | GETINGE: EU CE-Mark Reinstated for Cardiosave Intra-Aortic Balloon Pump | 1 | Cision News | ||
| 04.08.25 | Getinge AB: EU CE-Mark Reinstated for Cardiosave Intra-Aortic Balloon Pump | 256 | GlobeNewswire (Europe) | Press release
Gothenburg, Sweden, on August 4, 2025
Today, Getinge announces that the EU Notified Body TÜV SÜD has reinstated the EU CE Mark for Getinge's Cardiosave Intra-Aortic Balloon Pump (through... ► Artikel lesen | |
| 22.07.25 | Getinge's Maquet updates instructions for certain neonatal ventilators | 2 | MassDevice | ||
| 18.07.25 | Getinge Posts Robust Q2 With Organic Growth And Margin Gains, Stock Up | 2 | RTTNews |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 40,640 | 0,00 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Aktienrückkauf
Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort
09.01.2026... ► Artikel lesen | |
| ESSILORLUXOTTICA | 275,70 | -0,25 % | JEFFERIES stuft EssilorLuxottica auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für EssilorLuxottica auf "Buy" mit einem Kursziel von 350 Euro belassen. Kursgewinne der Aktien am Dienstag seien einem Artikel... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 146,50 | -0,61 % | Here's What to Expect From Align Technology's Next Earnings Report | ||
| INMODE | 12,440 | +0,28 % | InMode Q4 Preliminary Revenue Rises | ||
| ELEVANCE HEALTH | 315,00 | -2,02 % | Elevra transitions off OTCQB: Elevra Lithium (ASX:ELV) is moving from the OTCQB Venture Market over to the OTC ... | ||
| TENET | 167,00 | -2,34 % | TD Cowen senkt Kursziel für Tenet Healthcare auf 230 US-Dollar | ||
| BONESUPPORT | 17,040 | +0,18 % | Bonesupport Holding AB: Bonesupport Holding AB (publ) - Publishes Q3 2025 Interim Report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the third quarter 2025.
"Solid growth and new clinical... ► Artikel lesen | |
| ARJO | 2,986 | -0,20 % | Arjo announces date for 2025 year-end report and conference call | ||
| AMN HEALTHCARE SERVICES | 12,500 | 0,00 % | AMN Healthcare Services Inc: AMN Healthcare Announces Third Quarter 2025 Results | Quarterly revenue of $634 million and adjusted EBITDA of $58 million; GAAP income of $0.76/share and adjusted EPS of $0.39 DALLAS, Nov. 06, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:... ► Artikel lesen | |
| OSSDSIGN | 0,976 | -1,21 % | OssDsign AB: OssDsign appoints Mark Waugh as new CEO | Uppsala, Sweden, 10th December, 2025 - OssDsign AB (publ.) today announces the appointment of Mark Waugh as CEO, effective 1st January 2026. He most recently served as Senior Vice President - Commercial... ► Artikel lesen | |
| CHECK-CAP | 1,450 | 0,00 % | Humanoid Global gibt strategische Investition in MBody AI, Entwickler einer Autonomieplattform für verkörperte KI bekannt | - NICHT ZUR VERBREITUNG IN DEN VEREINIGTEN STAATEN ODER ÜBER US-NACHRICHTENDIENSTE BESTIMMT -
Vancouver, BC und Las Vegas, Nevada - 7. Januar 2026 / IRW-Press / Humanoid Global
... ► Artikel lesen | |
| FISHER & PAYKEL HEALTHCARE | 18,600 | 0,00 % | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: SPH Notice - AustralianSuper Pty Ltd | ||
| ALPHATEC | 15,425 | +2,29 % | Alphatec Holdings, Inc. and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion | ATEC Secures Exclusive U.S. Rights to OsteoAdapt® Platform in Major Strategic Alignment
Theradaptive Initiates Series B to Advance Proprietary Protein-Engineering... ► Artikel lesen | |
| CROSS COUNTRY HEALTHCARE | 7,050 | 0,00 % | Citizens maintains Cross Country Healthcare stock rating, cites discount to peer | ||
| STEREOTAXIS | 2,140 | -1,83 % | Stereotaxis, Inc.: Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter | ST. LOUIS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained... ► Artikel lesen |
GETINGE AB ADR gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 20,400 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GETINGE AB ADR finden Sie auf Wallstreet Online.